Teligent Inc (TLGT) Stock Price & Overview
NASDAQ:TLGT
Current stock price
The current stock price of TLGT is 0.1735 null. Today TLGT is down by -13.85%. In the past month the price decreased by -55.51%. In the past year, price decreased by -75.14%.
TLGT Key Statistics
- Market Cap
- 16.104M
- P/E
- N/A
- Fwd P/E
- 0.04
- EPS (TTM)
- -7.24
- Dividend Yield
- N/A
TLGT Stock Performance
TLGT Stock Chart
TLGT Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to TLGT. When comparing the yearly performance of all stocks, TLGT is a bad performer in the overall market: 99.72% of all stocks are doing better.
TLGT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TLGT. The financial health of TLGT is average, but there are quite some concerns on its profitability.
TLGT Earnings
TLGT Forecast & Estimates
For the next year, analysts expect an EPS growth of 131.61% and a revenue growth -16.85% for TLGT
TLGT Groups
Sector & Classification
TLGT Financial Highlights
Over the last trailing twelve months TLGT reported a non-GAAP Earnings per Share(EPS) of -7.24. The EPS increased by 27.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -197.78% | ||
| ROA | -101.27% | ||
| ROE | N/A | ||
| Debt/Equity | -2.67 |
TLGT Ownership
TLGT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.12 | 846.194B | ||
| JNJ | JOHNSON & JOHNSON | 20.64 | 576.236B | ||
| MRK | MERCK & CO. INC. | 23.12 | 294.041B | ||
| PFE | PFIZER INC | 9.06 | 156.828B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.24 | 121.027B | ||
| ZTS | ZOETIS INC | 16.01 | 49.233B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.97 | 27.078B | ||
| VTRS | VIATRIS INC | 5.2 | 15.394B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.99 | 12.22B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.402B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.647B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.596B | ||
| CORT | CORCEPT THERAPEUTICS INC | 45.51 | 4.098B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TLGT
Company Profile
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. The company is headquartered in Buena, New Jersey and currently employs 142 full-time employees. The firm is focused on the development, manufacturing and marketing of a portfolio of generic pharmaceutical products under its own label and private label for other pharmaceutical companies in topical, injectable, complex and other dosage forms. The company also provides contract development and manufacturing services to the prescription and over-the-counter (OTC) pharmaceutical and cosmetic markets. Under the Company's own label, it markets and sells generic topical, and generic and branded generic injectable pharmaceutical products in the United States and Canada. In the United States, the Company markets approximately 37 generic topical pharmaceutical products and one branded injectable pharmaceutical product. In Canada, it markets approximately 24 generic injectable, one generic topical and three generic ophthalmic products.
Company Info
IPO: 1981-07-30
Teligent Inc
105 Lincoln Avenue
Buena NEW JERSEY 08310 US
CEO: Timothy B. Sawyer
Employees: 142
Phone: 18566971441.0
Teligent Inc / TLGT FAQ
What does TLGT do?
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. The company is headquartered in Buena, New Jersey and currently employs 142 full-time employees. The firm is focused on the development, manufacturing and marketing of a portfolio of generic pharmaceutical products under its own label and private label for other pharmaceutical companies in topical, injectable, complex and other dosage forms. The company also provides contract development and manufacturing services to the prescription and over-the-counter (OTC) pharmaceutical and cosmetic markets. Under the Company's own label, it markets and sells generic topical, and generic and branded generic injectable pharmaceutical products in the United States and Canada. In the United States, the Company markets approximately 37 generic topical pharmaceutical products and one branded injectable pharmaceutical product. In Canada, it markets approximately 24 generic injectable, one generic topical and three generic ophthalmic products.
Can you provide the latest stock price for Teligent Inc?
The current stock price of TLGT is 0.1735 null. The price decreased by -13.85% in the last trading session.
What is the dividend status of Teligent Inc?
TLGT does not pay a dividend.
How is the ChartMill rating for Teligent Inc?
TLGT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What sector and industry does Teligent Inc belong to?
Teligent Inc (TLGT) operates in the Health Care sector and the Pharmaceuticals industry.
Should I buy TLGT stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TLGT.